Neonates: Bacteriostatic Water for Injection is contraindicated in neonates (newborn infants), especially premature infants
Those two rules cover 90% of the questions people have
That does not establish what SubQ KPV does in human skin, and no published subcutaneous human study has measured a KLOW skincare outcome. Regulatory status KLOW as a pre-mixed blend has not been evaluated by the FDA
For the initial treatment of vitamin B12 deficiency, the usual dose is 100mcg SC/MC, given every day for 10-15 days, followed by maintenance treatment
Treatment if appropriate: If the service is suitable, the injection is administered in the private consultation room
Independent testing and MHRA enforcement activity (including Operation Pangea) have found that many such products contain incorrect concentrations, impurities, or in some cases entirely different substances to those labelled